SCHEMBL7974015

SCHEMBL7974015

O=c1nc(-c2cccc(Cl)c2)[nH]c2ncn(Cc3ccccc3)c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARN O95453 1/20 0.49
CNOT7 Q9UIV1 1/20 0.49
CXCR2 P25025 1/20 0.49
PGR P06401 3/20 0.46
ACP1 P24666 1/20 0.44
SMN1; SMN2 Q16637 5/20 0.43
GLA P06280 1/20 0.43
HTT P42858 1/20 0.43
UBE2N P61088 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PIN1 Q13526 3/20 0.43
IDO1 P14902 1/20 0.42
PNP P00491 1/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPK1 P28482 1/20 0.41
USP2 O75604 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7973628 0.96 SMN1; SMN2 (0.48) PARNCNOT7CXCR2PGRACP1
SCHEMBL7988669 0.94 PARN (0.48) PARNCNOT7CXCR2PGRACP1
SCHEMBL7975243 0.91 HTT (0.44) PARNCNOT7CXCR2ACP1SMN1; SMN2
SCHEMBL7985362 0.91 GRIN1 (0.45) PARNCNOT7CXCR2ACP1SMN1; SMN2
SCHEMBL7988553 0.90 CNOT7 (0.50) PARNCNOT7CXCR2PGRACP1
SCHEMBL7988784 0.90 MAPK1 (0.43) PARNCNOT7CXCR2ACP1SMN1; SMN2
SCHEMBL7991600 0.90 ACP1 (0.42) PARNCNOT7CXCR2ACP1SMN1; SMN2
SCHEMBL7975271 0.90 CNOT7 (0.56) PARNCNOT7CXCR2SMN1; SMN2PNP
SCHEMBL7991568 0.89 SMN1; SMN2 (0.45) PARNCNOT7CXCR2ACP1SMN1; SMN2
SCHEMBL7984663 0.89 CNOT7 (0.49) PARNCNOT7SMN1; SMN2PNPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed